Tus kws kho mob
P69-20 Update Early Intensive Developmental and Behavioral Intervention (EIDBI) Authorization Process
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2441 - 2450 ntawm 3289
Tus kws kho mob
P65-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P70-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective November 2, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P68-20 Radiology Cardiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P64-20 Update to the Common Carrier and Special Transportation Services Addendums
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P66-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
QP82-20 Commercial Pharmacy Benefit Exclusion for Amzeeq™ (minocycline) foam, brimonidine ophthalmic solution 0.15% and ProAir® (albuterol sulfate) HFA
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP80-20 MHCP Pharmacy Benefit Update - AvsolaTM, Ilaris® and PerserisTM
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP78-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa®
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP77-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020